FindTrial
Sign In

Study on schizophrenia

Exploring the molecular links between Klotho and Kynurenic acid, the two important molecules of cognition

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033567
Enrollment
200
Registered
2021-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

Intervention1: NOT APPLICABLE: NOT APPLICABLE Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

DST CSRI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed as schizophrenia according to DSM V criteria on treatment or treatment naive 2.Schizophrenia patients with or without negative symptoms

Exclusion criteria

Exclusion criteria: 1. Patients with severe positive symptoms 2. Patients with active substance abuse or dependence

Design outcomes

Primary

MeasureTime frame
Klotho Kynurenic acid Cognitive markersTimepoint: One time—

Secondary

MeasureTime frame
NATimepoint: NA—

Countries

India

Contacts

Public ContactVijaya Majumdar

SVYASA University

majumdar.vijaya@gmail.com9036800821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026